Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 1998

View Archived Issues

Shire: Interim Report 1997

PD-72953 raises HDL by activating a peroxisomal receptor?

Company Profile: Sheffield Pharmaceuticals

QLT and Ciba Vision initiate phase IIIb verteporfin trial

Ebselen therapy more cost-effective than standard therapy

Progenics' HIV products show promise in phase I/II clinical trials

Mochida describes PDE V inhibitors for pulmonary hypertension, ischemic heart disease

Compounds modulating apolipoprotein production in development at Nisshin Flour Milling

Antiplatelet agents reported by researchers at Nippon Steel

Lilly reveals new series of hypoglycemic/hypolipidemic compounds

New antineoplastic glutamic acid derivatives synthesized at Princeton

Selective functional AMPA antagonists patented by ADIR

Botox effective in controlling focal hyperhidrosis

Flamel Technologies: Q4 and year-end 1997 highlights

Approval recommended for Gemzar supplemental NDA

T-20 + efavirenz + protease inhibitors to be evaluated in HIV patients

Vitamin C prevents development of nitrate tolerance in CHF

Schering-Plough and Chugai sign marketing agreement for psoriasis drug

Patient enrollment completed for phase III studies of pramlintide

Fluoxetine for premature ejaculation

Polyether from marine sponge possesses both antitumor and antifungal properties

Daiichi to market Nycomed Amersham's ultrasound contrast agent in Japan

CEA-Scan to be distributed by Bergen Brunswig in U.S.

U. of Alberta researchers discover novel 1,4-dihydropyridine calcium channel modulators

Introgen granted option for tumor suppressor gene

Progress made in Lilly/Emisphere protein delivery collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...